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Abstract
Anaerobic bacteria have been identified in abundance in the airways of cystic fibrosis (CF)
subjects. The impact their presence and abundance has on lung function and inflammation
is unclear. The aim of this study was to investigate the relationship between the colony
count of aerobic and anaerobic bacteria, lung clearance index (LCI), spirometry and C-Re-
active Protein (CRP) in patients with CF. Sputum and blood were collected from CF patients
at a single cross-sectional visit when clinically stable. Community composition and bacterial
colony counts were analysed using extended aerobic and anaerobic culture. Patients com-
pleted spirometry and a multiple breath washout (MBW) test to obtain LCI. An inverse corre-
lation between colony count of aerobic bacteria (n = 41, r = -0.35; p = 0.02), anaerobic
bacteria (n = 41, r = -0.44, p = 0.004) and LCI was observed. There was an inverse correla-
tion between colony count of anaerobic bacteria and CRP (n = 25, r = -0.44, p = 0.03) only.
The results of this study demonstrate that a lower colony count of aerobic and anaerobic
bacteria correlated with a worse LCI. A lower colony count of anaerobic bacteria also corre-
lated with higher CRP levels. These results indicate that lower abundance of aerobic and
anaerobic bacteria may reflect microbiota disruption and disease progression in the CF
lung.
Introduction
Cystic Fibrosis (CF) lung disease is characterised by inflammation, recurring and chronic infec-
tion causing lung injury, progressive loss of lung function and eventual respiratory failure.
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Bacterial species such as Pseudomonas aeruginosa, Staphylococcus aureus and Burkholderia
cepacia complex (Bcc) are considered to be the predominant pathogens responsible for CF
lung infection [1–3]. However, extended culture and molecular detection methods have dem-
onstrated that there is much greater bacterial diversity in the CF lung than previously thought,
with aerobic and anaerobic bacteria, fungi and viruses all contributing to a complex airway
microbiota [4–7]. Anaerobic bacteria have been identified in abundance in a wide age range of
CF patients [5,6]; however, their clinical relevance and specific role, if any, in pulmonary infec-
tion and inflammation requires further study.
The presence of anaerobic bacteria not previously detected by culture may be an explanation
as to why some CF patients have evidence of pulmonary inflammation in the absence of
known pathogens or why some patients fail to respond clinically to antibiotic treatment [8,9].
Anaerobic species such as Prevotella, possess known virulence factors and may facilitate and
create a favourable environment for other bacterial organisms to colonise [10]. Conversely, di-
rect evidence of a correlation between the presence and/or abundance of anaerobic bacteria
and lung disease progression in CF is lacking [11] and it may be possible that these bacteria
constitute part of the healthy lung microbiota where disruption may lead to disease, as sug-
gested in studies of COPD and asthma [12,13]. Study of the association between the abundance
of anaerobic bacteria and lung disease severity in CF is required to help determine if anaerobic
bacteria contribute to the pathogenesis of CF lung disease.
Lung Clearance Index (LCI) derived fromMultiple Breath Washout (MBW) is a robust sur-
rogate outcome measure of lung disease in CF [14] and was the primary measure of interest in
this study. LCI measures ventilation inhomogeneity, i.e. uneven gas mixing throughout the
lungs which has been shown to be more sensitive to lung function abnormality than FEV1%
predicted [15], a discriminator of airway infection in patients with P. aeruginosa and S. aureus
[16,17] and a predictor of time to first pulmonary exacerbation (PEx).[18]
The aim of this study was to assess the relationship between microbial colony count (aerobic
and anaerobic bacteria) and community composition and (i) LCI (ii) spirometry and (iii) C—
reactive protein (CRP); in patients with CF. Data from healthy controls provided a
comparator group.
Methods
Patients
Adults and children (aged 6 years), with a confirmed diagnosis of CF [19] who were clinical-
ly stable (no PEx requiring intravenous antibiotics [IVAB] in the previous 4 weeks) were re-
cruited from outpatient clinics at the adult and paediatric CF Centres at Belfast Health and
Social Care Trust (BHSCT) and data was collected at a single cross-sectional visit. Patients with
Bcc infection were excluded due to issues relating to infection control with MBW equipment.
Healthy control patients (aged 18years) were recruited from staff groups at Queen’s Uni-
versity Belfast (QUB) and BHSCT. Exclusion criteria were (1) diagnosis of a respiratory condi-
tion, (2) use of respiratory medication or antibiotics in the last 4 weeks, (3) current smoker or
(4) participating in an investigational clinical trial in the previous 4 weeks.
Sputum collection and bacterial isolation and identification
Expectorated and induced sputum samples were collected from CF patients and healthy sub-
jects, respectively. Control subjects performed an induced sputum procedure using 7% hyper-
tonic saline and an Omron MicroAIR NE-U22-E nebuliser. Subjects were instructed to take
3–4 tidal breaths interspersed with 1–2 deep breaths and stop the inhalation every 1 to 2 min-
utes in order to cough up sputum. Saliva and sputum was collected in the same container. This
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cycle was continued as tolerated until an adequate volume of sputum (>1g) was collected.
Samples were immediately placed in an anaerobic pouch and transported to the laboratory for
processing in an anaerobic cabinet. Strict aerobic and anaerobic bacteriological culture tech-
niques were used to provide an in-depth analysis of the microbiota composition and abun-
dance of aerobic and anaerobic bacteria. Culture and subsequent detection of isolates in
samples was performed as detailed in S1 File and as previously described [5,6] with all bacteria
detected quantified (colony forming units/gram sputum; [cfu/g]) by total viable count (TVC)
and identified by PCR and sequencing of 16S ribosomal genes.
Clinical data
Demographic data were recorded from CF patient’s notes. Infection with P. aeruginosa was de-
fined using the Leeds criteria [20]. High sensitivity blood CRP was measured by turbidimetric
immunoassay in QUB laboratories, from a blood sample taken on the same day.
MBW test
The MBW test to measure LCI was carried out using the modified Innocor device and 0.2%
sulfur hexafluoride (SF6) using the open-circuit technique in accordance with the standard op-
erating procedure developed by the UK CF Gene Therapy Consortium (UKCFGTC) (S2 File).
This technique was previously validated by Horsley et al.[15] and replicated at the Belfast site
[21] Furthermore, it has been incorporated into CF clinical trials [22,23]. Patients breathed
through a mouthpiece at normal tidal volumes, whilst in a seated position and wearing a nose
clip. Analysis of MBW data was performed using the Simple Washout programme developed
by Dr Nicholas Bell (UKCFGTC) and used with his permission. LCI was calculated from a
minimum of 2 technically valid and repeatable tests (S2 File).
Spirometry
Spirometry was measured according to ATS/ERS guidelines [24] using a Microlab (ML3500
MK8) spirometer (CareFusion, Kent, UK). Predicted values and z-scores were calculated from
reference ranges for all ages [25].
Data analysis
No formal sample size calculation was carried out. Data were analysed using PASW Statistics
(version 18, IBM software, USA) and Prism (Version 5.01 GraphPad Software Inc.) packages.
Subject characteristics were summarised with standard descriptive statistics. Colony count of
aerobic and anaerobic bacteria and blood CRP were log10 transformed for statistical analysis.
Wilcoxon signed rank tests were used to assess for differences between the colony count of aer-
obic and anaerobic bacteria in samples from CF patients and control subjects. A Spearman’s
rank correlation coefficient was used to measure the strength of the linear association between
LCI, FEV1 z-score and colony counts (aerobic, anaerobic bacteria) and between colony count
(aerobic, anaerobic bacteria) and CRP. Multiple linear regression analysis was used to assess
the contribution of potential confounding factors in predicting colony counts. A p-value of
<0.05 was considered statistically significant. This study was approved by the Office for Re-
search Ethics Committees Northern Ireland (ORECNI) (REC reference number: 10/NIR01/41)
and co-sponsored by BHSCT and QUB (research office reference number: 10067SE-OPMS).
Patients or their parents provided written informed consent as approved by ORECNI.
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Results
Patients
Sixty-three CF patients and 17 healthy control subjects were enrolled and attempted the study
procedures at a single study visit. The induced sputum procedure was attempted in control
subjects only in this study and was not attempted in CF patients due to lack of time (study visits
were conducted as part of a routine outpatient appointment). Only a small number of healthy
control subjects (n = 6; 35%) produced an adequate volume of induced sputum. Forty-one
(65%) CF patients produced adequate volumes of sputum for culture analysis (S1 Fig). There-
fore, full data was analysed for 41 CF patients and 6 healthy control subjects.
In the 41 CF patient and 6 control subjects included in analysis, there was no difference in
age, sex or LCI CV% between the 2 groups. However, there were significant differences in
FEV1% predicted, FEV1 z-score and LCI (Table 1).
Culture analysis of lung microbiota composition in CF patients and
control subjects
In patients with CF, bacteria were detected in high abundance (up to 2.1 x 109 cfu/g) in the 41
sputum samples. A mean (SD) [range] of 6.7 (1.8) [3–11] different genera were cultured per
sample with a median (IQR) colony count of 5.8 x 107 (2.3 x 107–1.9 x 108) cfu/g sputum. Aero-
bic bacteria from 25 different genera were isolated in high abundance (up to 1.4 x 109 cfu/g) in
all samples with Streptococcus (40/41 patients), Rothia (29/41 patients), Staphylococcus (20/41
patients), Actinomyces (20/41), Pseudomonas (20/41 patients), Gemella (17/41 patients), the
predominant genera detected. Anaerobic bacteria from 12 different genera were also detected
in high numbers (up to 2.0 x 109 cfu/g) from 38 of 41 samples (93%), with Prevotella (34/41 pa-
tients) and Veillonella (22/41 patients) most frequently isolated. Aerobic bacteria were present
in significantly greater numbers than anaerobic bacteria (median difference in colony count
5.0 x 107 cfu/g; Wilcoxon signed rank test, p<0.0001) (Fig 1).
In the 6 induced sputum samples from control patients, bacteria were also detected in abun-
dance (up to 3.7 x 107 cfu/g). A mean (SD) [range] of 8.3 (1.5) [7–11] different genera were cul-
tured per sample with a median (IQR) colony count of 1.4 x 107 (7.1 x 106–3.3 x 107) cfu/g
sputum. Aerobic bacteria from 10 different genera were isolated in high abundance (up to
1.4 x 107 cfu/g) in all samples with Streptococcus (6/6), Haemophilus (6/6) and Rothia (6/6),
most frequently isolated. Anaerobic bacteria from 3 different genera were also detected in high
Table 1. CF patient and healthy control subject characteristics.
CF n = 41 Control n = 6 p-value
Mean (SD) age [range] (years) 29.2 (14.0) []8–67 34.0 (9.0) [24–44] 0.28
Females:males (n) 15:26 4:2 0.16
N (%) F508del homozygous 12/41 (29) n/a n/a
N (%) chronic P. aeruginosa 20/41 (49) n/a n/a
Mean (SD) FEV1% predicted 71.2 (16.6) 101.3 (11.8) <0.001
Mean (SD) FEV1 z-score -2.4 (1.3) 0.1 (1.0) <0.001
Mean (SD) LCI [range] (no. turnovers) 10.6 (2.6) [5.4–16.4] 6.4 (0.4) [5.8–7.0] <0.001
Mean (SD) LCI coefﬁcient of variation (CV) % 4.4 (2.6) 3.4 (2.0) 0.44
N (%) anti-pseudomonal antibiotica 24/41 (59) n/a n/a
N (%) oral azithromycin 23/41 (56) n/a n/a
aOral and/or inhaled anti-pseudomonal
doi:10.1371/journal.pone.0126980.t001
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numbers (up to 6.4 x 106 cfu/g) in all samples, with Prevotella (6/6 patients) and Veillonella
(3/6 patients) most frequently detected. There was no significant difference between colony
count of aerobic and anaerobic bacteria (median difference in colony count 2.1 x 106 cfu/g;
Wilcoxon signed rank test, p = 0.08) (Fig 1).
Relationship between lung function and microbial colony counts
In CF samples, there was a significant inverse correlation between total colony count and LCI
(r = -0.42; p = 0.007) (Fig 2A). Considering aerobic and anaerobic bacteria separately, there
was a significant inverse correlation between LCI and colony count of aerobic bacteria (r =
-0.35; p = 0.02) and anaerobic bacteria (r = -0.44; p = 0.004), indicating that a lower colony
count was associated with a higher i.e. worse LCI. (Fig 2B and 2C).
The relationships between FEV1 z-score and total colony count (r = 0.19; p = 0.23), colony
count of aerobic (r = 0.18; p = 0.26) and anaerobic (r = 0.14; p = 0.38) bacteria in CF samples
were not significant (Fig 3A–3C). Similarly, the relationship between FEF25–75 z-score and total
Fig 1. Total colony count, aerobic colony count and anaerobic colony count of bacteria in sputum fromCF patients and control subjects. (Median).
doi:10.1371/journal.pone.0126980.g001
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Fig 2. Relationship between LCI and a) total colony count b) aerobic colony count and c) anaerobic
colony count.
doi:10.1371/journal.pone.0126980.g002
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Fig 3. Relationship between FEV1 z-score and a) total colony count b) aerobic colony count and c)
anaerobic colony count.
doi:10.1371/journal.pone.0126980.g003
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colony count (r = 0.26; p = 0.12), colony count of aerobic (r = 0.18; p = 0.29) and anaerobic
(r = 0.27; p = 0.10) bacteria in CF samples were not significant.
Considering other factors that could potentially impact results, there was no correlation be-
tween age and aerobic (r = -0.19; p = 0.24) or anaerobic colony counts (r = 0.15; p = 0.35). Fur-
thermore, no anaerobic bacteria were detected by culture in 3 samples; when excluded from
analysis, the correlation between LCI and anaerobic colony count remained statistically signifi-
cant (r = -0.50; p = 0.001) and the correlation between FEV1 z-score and colony count of anaer-
obic bacteria remained not significant (r = 0.16; p = 0.35).
As Prevotella and Veillonella were the most abundant anaerobic organisms detected in CF
samples in this study (82% and 54% of samples, respectively), we assessed the relationship be-
tween these genera and lung disease severity. An inverse correlation was observed between
abundance of Veillonella, LCI (r = -0.80; p<0.0001) and FEV1 z-score (r = 0.64; p = 0.001) (S2
Fig). However, a relationship was not evident between the abundance of Prevotella, LCI (r =
-0.12; p = 0.50) or FEV1 z-score (r = -0.06; p = 0.74).
Twenty of 41 (49%) patients were chronically colonised with P. aeruginosa; these patients
had a significantly lower colony count of both aerobic (p = 0.03) (including P. aeruginosa) and
anaerobic bacteria (p = 0.04) compared to patients not chronically colonised. The relationship
between LCI and colony count of both anaerobic (r = -0.43, p = 0.06) and aerobic bacteria (r =
-0.38, p = 0.10) were of moderate strength but not statistically significant in this cohort (Fig
4A).
In the 21/41 (51%) patients without chronic P. aeruginosa infection, the relationship be-
tween LCI and colony count of anaerobic bacteria was not significant (r = -0.29; p = 0.21),
heavily influenced by one outlier value (Fig 4B). When this outlier was excluded, an inverse
correlation was observed (r = -0.47, p = 0.04). The relationship between LCI and colony count
of aerobic bacteria was not significant (r = -0.12, p = 0.61). There was no relationship between
colony count of pseudomonas where present (20/41; 49%) and either LCI (r = 0.04; p = 0.86)
or FEV1 z-score (r = -0.23; p = 0.36).
Impact of antibiotics on microbial colony counts
There was no significant difference in the colony count of aerobic (p = 0.16) or anaerobic bac-
teria (p = 0.06) between patients on anti-pseudomonal treatment compared with patients not
on treatment. There was also no significant difference in the colony count of aerobic (p = 0.22)
or anaerobic bacteria (p = 0.15) between patients on azithromycin treatment compared with
patients not on treatment. Using a regression model, neither anti-pseudomonal (beta = -0.11;
p = 0.55) nor azithromycin treatment (beta = -0.04; p = 0.85) were shown to be significant pre-
dictors of anaerobic colony count.
Relationship between CRP and microbial colony counts
Blood CRP results were available for 25 CF patients. Patients had a median (IQR) CRP of 330.0
(990.4.0–119.8) μg/dl. There was an inverse correlation between colony count of anaerobic bac-
teria and CRP (r = -0.44; p = 0.03) (Fig 5). However, the correlation between colony count of
aerobic bacteria and CRP (r = -0.05; p = 0.82) was not significant.
Discussion
This is the first study to examine the relationship between colony count of aerobic and anaero-
bic bacteria, lung disease severity as measured by LCI and spirometry, and inflammation, in a
clinically stable group of children and adults with CF. Results of this study demonstrate
Anaerobic Bacteria and Lung Clearance Index in Cystic Fibrosis
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important relationships between aerobic and anaerobic bacteria and LCI, and between anaero-
bic bacteria and inflammation.
Fig 4. Relationship between anaerobic and aerobic colony count and LCI in CF patients with a) chronic P. aeruginosa infection and b) without P.
aeruginosa infection.
doi:10.1371/journal.pone.0126980.g004
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Extended aerobic and anaerobic culture of CF samples revealed the presence of complex
polymicrobial communities with a high abundance of aerobic and anaerobic genera previously
detected in studies by this group and others [6,7]. Results from sample analysis of healthy con-
trols also reveal a diverse airway microbiota with similarities in some of the aerobic (Gemella,
Staphylococcus) and anaerobic (Prevotella, Veillonella) bacteria detected, demonstrating that
these genera reside in healthy lungs in the presence of normal LCI and FEV1 values. Further-
more, this suggests that these anaerobic bacteria may represent part of the normal flora of the
airway microbiota, as shown by other studies [26–28].
Within the CF group, patients with a higher colony count of aerobic and anaerobic bacteria
had a better LCI, indicating better lung function. In relation to anaerobes, results from a previ-
ous study by Zemanick et al. support these findings, where the presence of anaerobes deter-
mined by pyrosequenecing at the time of a PEx was associated with a better lung function as
measured by FEV1% predicted, compared with the presence of Pseudomonas. Relative abun-
dance of Prevotella also inversely correlated with serum CRP [11]. The predominant anaerobic
genera detected in CF samples in this study (Prevotella, Veillonella) have been recognised as
members of the “core” group in the lung microbiota in CF [29]. Worse LCI in patients with a
lower colony count of anaerobic bacteria, may reflect disruption in the composition of the core
microbiota and lung disease progression, as has been suggested in COPD [12,28]. The signifi-
cant inverse correlation between colony count of anaerobic bacteria and CRP values further
supports the hypothesis that a decrease in colony count of anaerobic bacteria may be associated
with more inflammation and possibly disease progression.
There was also a significant inverse correlation between colony count of aerobic bacteria
and LCI. This result was not expected, given that several studies have shown that increased aer-
obic pathogen colony count is associated with worse clinical outcomes in CF [5,30]. However,
this finding may be explained by the fact that, in the present study, the colony count of aerobic
Fig 5. Relationship between colony count of anaerobic bacteria and CRP.
doi:10.1371/journal.pone.0126980.g005
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bacteria contained both typical CF pathogens and aerobic bacteria recently identified as mem-
bers of the CF airway microbiota such as Rothia, Gemella and Neisseria.
The relationship between P. aeruginosa infection and lung function as measured by spirom-
etry and LCI is well established [1,17]. A number of studies have also reported decreased diver-
sity in the lung microbiota in patients with chronic P. aeruginosa infection, in association with
worse lung function [4,11]. Findings from this study of significantly lower counts of anaerobic
bacteria, in patients with chronic P. aeruginosa infection, provide further evidence of an associ-
ation between low diversity and dominance with P. aeruginosa infection. However, (excluding
the outlier) the relationship between LCI and colony count of anaerobic bacteria was only sig-
nificant in those patients without P. aeruginosa infection. This result highlights that the associ-
ation between decreasing diversity and lung function may also be important to consider in
patients without P. aeruginosa infection.
The use of extended aerobic and anaerobic culture techniques in this study was advanta-
geous as it enabled the detection of organisms of interest and a quantitative estimation of their
bacterial load. However, pyrosequencing methods may have enabled a more comprehensive
characterisation of airway microbial community composition and provided further evidence of
a relationship between diversity and lung disease severity.
These findings highlight the improved sensitivity of LCI compared with FEV1 z-score,
which did not detect any significant relationships with colony counts. As LCI is representative
of disease processes in the peripheral airways, to which FEV1 is insensitive, it may provide a
more sensitive measure of the impact of infection on the airways. This has been demonstrated
in a study of known CF pathogens (P. aeruginosa, S. aureus), where LCI was a more sensitive
discriminator between infection type, compared with FEV1% predicted [16]. Although there
was no significant relationship between small airways function, as measured by FEF25–75 z-
score, and colony counts, the variation within the measure mean can be unreliable. A body of
evidence now exists to demonstrate the superior sensitivity of LCI compared with FEV1 in
younger CF patients with mild lung disease [14]. Our study demonstrates that LCI is also sensi-
tive in older patients with more severe lung disease, as well as younger patients with milder dis-
ease with superior discriminatory power compared with FEV1 z-score.
Although the difference in anaerobic colony count between patients taking anti-pseudomo-
nal treatment versus patients not taking treatment was not statistically significant, the median
difference (4.0 x 106 cfu/g) trended towards a lower count in those taking treatment (p = 0.06).
Although treatment was not shown to be a significant predictor of anaerobic colony count in
this study, other studies have highlighted antibiotic treatment as a primary driver for changes
in microbiota community structure [31] and should be considered in future studies.
This study has a number of limitations including the small number of healthy control sub-
jects analysed (n = 6) due to inadequate volumes of induced sputum produced. This was also a
challenge in CF patients where 21/63 (33%) patients did not expectorate adequate sputum for
culture analysis. These CF patients were likely to be less symptomatic with better lung function
and these results may not extrapolate to this patient group. Although the CF group studied had
a wide age range (8–67), the majority were older (mean 29.2 years), potentially impacting on
the applicability of these results to a younger age group. Finally, these data are from a single
time point and further study of larger numbers over longitudinal time points are required to
confirm these relationships.
The authors acknowledge that the relationships demonstrated between LCI and colony
counts, and between colony counts and CRP were only of moderate strength (r = -0.44). The
relationship between the presence of anaerobic bacteria and lung disease severity may be affect-
ed by the presence of other aerobic or anaerobic bacteria. A number of studies have demon-
strated that the presence of polymicrobial infection can lead to synergistic interactions,
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affecting the pathogenicity of aerobic and anaerobic bacteria within the lung [32,33]. Further-
more, infectious processes may also be affected by interactions between microbes and the host.
Therefore, the strength of relationship between disease severity and anaerobes may be influ-
enced by the specific airway microbiota composition in each individual.
Conclusions
This is the first study to show that a lower colony count of aerobic and anaerobic bacteria cor-
related with a worse LCI. A lower colony count of anaerobic bacteria also correlated with
higher CRP levels. These results indicate that lower abundance of aerobic and anaerobic bacte-
ria may reflect microbiota disruption and disease progression in the CF lung.
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